The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support ...

Milestone Pharmaceuticals (MIST) stock falls amid a capital raise as FDA agrees to review its resubmitted NDA for heart therapy Cardamyst. Read more here.

Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (Milestone) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in the ...

Vaccine experts have developed an antibody that, when applied to the nose, intercepts allergens before they can trigger a ...

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.

"We are thrilled to bring the SONU Band to Android users now," said Dr. Paramesh Gopi, founder and CEO of SoundHealth. "Our ...

Probation officials said youths and staff members were hospitalized after a 'suspected overdose and possible exposure to an ...

When planning for your trip, keep possible nasal polyp triggers in mind, including changes in air pressure, exposure to ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

Vending machines throughout Denver have distributed more than 1,800 free boxes of the overdose reversal medication naloxone since they debuted in April.